The Latin America, Middle East and Africa Attention Deficit Hyperactivity Disorder Market would witness market growth of 7.3% CAGR during the forecast period (2022-2028).
As novel treatments are released, it will be crucial to assess their cost-effectiveness to give clinicians, third-party payers, patients, and families an idea of their potential worth. In the near future, the market expansion is anticipated to be driven by extensive research studies carried out by organizations to assess the safety and efficacy of medications in patients with ADHD. Positive findings from these investigations create new business prospects.
For example, alpha-2-adrenergic agonists like guanfacine & clonidine, according to a Boston Children's Hospital study from 2021, can be helpful in reducing illness symptoms in children. Additionally, it is shown that these drugs have fewer adverse side effects than other stimulants such as amphetamines (Adderall, Vyvanse), methylphenidate (Ritalin, Concerta), and caffeine, which are frequently used as initial treatments for the disorder. Therefore, the expansion of essential players’ efforts to promote their products is creating new economic opportunities.
Several studies have established a high variation in the prevalence of ADHD in Brazil. Nearly 65% of diagnosed children with ADHD have also continued to show the symptoms of the disorder well into adulthood. This further suggested that ADHD can be regarded as a chronic developmental disorder in the nation. Similarly, in the Middle East region, the prevalence of ADHD was assessed based on the DSM-IV guidelines in Egypt, Palestine, Saudi Arabia, Tunisia, Oman, Qatar, Lebanon, Tunisia, and Iraq.
The Brazil market dominated the LAMEA Attention Deficit Hyperactivity Disorder Market by Country in 2021; thereby, achieving a market value of $199.4 million by 2028. The Argentina market is showcasing a CAGR of 7.9% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 7% during (2022 - 2028).
Based on Drug Type, the market is segmented into Stimulants and Non-stimulants. Based on Stimulants Type, the market is segmented into Amphetamine, Methylphenidate, Lisdexamfetamine and Dexmethylphenidate. Based on Non-stimulants Type, the market is segmented into Atomoxetine, Guanfacine, Clonidine and Others. Based on Demographics, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Retail Pharmacy and Hospital Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Attention Deficit Hyperactivity Disorder Market is Predict to reach $16.9 Billion by 2028, at a CAGR of 4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, Pfizer, Inc. (Global Blood Therapeutics, Inc.), Johnson & Johnson (Johnson & Johnson Services, Inc.), Lupin Limited, Novartis AG, Takeda Pharmaceutical Company Limited, Mallinckrodt PLC, Purdue Pharma L.P., Aytu BioPharma, Inc. and Supernus Pharmaceuticals, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Stimulants
- Amphetamine
- Methylphenidate
- Lisdexamfetamine
- Dexmethylphenidate
- Non-stimulants
- Atomoxetine
- Guanfacine
- Clonidine
- Others
By Demographics
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Eli Lilly And Company
- Pfizer, Inc. (Global Blood Therapeutics, Inc.)
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Lupin Limited
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Mallinckrodt PLC
- Purdue Pharma L.P.
- Aytu BioPharma, Inc.
- Supernus Pharmaceuticals, Inc.
TABLE 1 LAMEA Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 8 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 9 LAMEA Amphetamine Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Amphetamine Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Methylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Methylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Non-stimulants Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Non-stimulants Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 20 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 21 LAMEA Atomoxetine Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Atomoxetine Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Guanfacine Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Guanfacine Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Clonidine Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Clonidine Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 30 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 31 LAMEA Adults Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Adults Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Children Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Children Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
TABLE 43 Brazil Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 44 Brazil Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 45 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 48 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 49 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 50 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 51 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 52 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 53 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 Argentina Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 56 Argentina Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 57 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 58 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 59 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 60 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 61 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 62 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 63 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 64 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 65 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 UAE Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 68 UAE Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 69 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 70 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 71 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 72 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 73 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 74 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 75 UAE Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 76 UAE Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 77 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 80 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 81 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 82 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 83 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 84 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 85 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 86 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 87 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 88 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 89 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 90 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 91 South Africa Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 92 South Africa Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 93 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 94 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 95 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 96 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 97 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 98 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 99 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 100 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 101 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 102 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 103 Nigeria Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 104 Nigeria Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 105 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 106 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 107 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 108 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 109 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 110 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 111 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 112 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 113 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 114 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 115 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 116 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 117 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 118 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 119 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 120 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 121 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 122 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 123 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 124 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 125 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 126 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 127 Key Information – Eli Lilly And Company
TABLE 128 Key Information – Pfizer, Inc.
TABLE 129 Key Information – Johnson & Johnson (Johnson & Johnson Services, Inc.)
TABLE 130 Key Information – Lupin Limited
TABLE 131 Key Information – Novartis AG
TABLE 132 Key Information – Takeda Pharmaceutical Company Limited
TABLE 133 Key information – Mallinckrodt PLC
TABLE 134 Key Information – Purdue Pharma L.P.
TABLE 135 Key Information – AYTU BIOPHARMA, INC.
TABLE 136 Key Information – Supernus Pharmaceuticals, Inc.
List of Figures
FIG 1 Methodology for the research